
Lim Flow Sa
Medical Devices, 2934 Scott BLVD, Paris, California, 95054, United States, 11-50 Employees
Phone Number: 33*********
Who is LIMFLOW SA
LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage Critical Limb Ischemia (CLI) patients, when all other revascularization efforts have been exha...
Read More

-
Headquarters: 2934 Scott BLVD, Paris, California, 95054, United States
-
Date Founded: 2012
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 5511
Does something look wrong? Fix it. | View contact records from LIMFLOW SA
LimFlow SA Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding LimFlow SA
Answer: LimFlow SA's headquarters are located at 2934 Scott BLVD, Paris, California, 95054, United States
Answer: LimFlow SA's phone number is 33*********
Answer: LimFlow SA's official website is https://limflow.com/home
Answer: LimFlow SA's revenue is $10 Million to $25 Million
Answer: LimFlow SA's SIC: 5511
Answer: LimFlow SA has 11-50 employees
Answer: LimFlow SA is in Medical Devices
Answer: LimFlow SA contact info: Phone number: 33********* Website: https://limflow.com/home
Answer: LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage Critical Limb Ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach. CLI is the most severe form of peripheral artery disease (PAD) and often occurs in patients suffering from coronary artery disease, diabetes, obesity, high cholesterol and high blood pressure. Patients with this chronic disease experience profound, chronic pain and if untreated can develop festering wounds or infections that lead to major limb amputation, an event closely associated with increased mortality and reduced quality of life. To relieve the symptoms of CLI, patients are typically treated with Percutaneous Transluminal Angioplasty (PTA) or with open and complex Distal Bypass Surgery (DBS). In many late-stage patients, neither option is feasible due to extensive disease in the target arteries or other anatomical constraints. The LimFlow procedure reinvents the anatomy in a percutaneous treatment that diverts blood around diseased arteries and into the tibial vein to perfuse an ischemic foot. Our proprietary technologies and expertise enable Vascular Specialists to provide new hope for their "Desert Foot" patients by delivering high levels of oxygenated blood flow hence promoting wound healing and reduced amputation rates.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month